MultiCell Technologies, Inc. and Xenogenics Corporation. MultiCell develops, sells and licenses hepatic or liver cells, cell lines and associated products to be used in drug development, diagnostic and therapeutic applications. MultiCell has developed proprietary immortalized human hepatocytes (liver cells) that have been genetically manipulated to allow them to replicate while retaining liver function. This allows for the continuous growth, and therefore supply, of human liver cells. Xenogenics is a majority-owned subsidiary that is developing a proprietary bio-artificial liver support device that utilizes MultiCell's immortalized cells.